LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer.

Vezelis, Alvydas; Simiene, Julija; Dabkeviciene, Daiva; Kincius, Marius; Ulys, Albertas; Suziedelis, Kestutis; Jarmalaite, Sonata; Jankevicius, Feliksas

Vezelis, Alvydas; Simiene, Julija; Dabkeviciene, Daiva; Kincius, Marius; Ulys, Albertas; Suziedelis, Kestutis; Jarmalaite, Sonata; Jankevicius, Feliksas.

Afiliación

Vezelis A; National Cancer Institute, Santariskiu Street 1, Vilnius, LT 08660, Lithuania.
Simiene J; National Cancer Institute, Santariskiu Street 1, Vilnius, LT 08660, Lithuania.
Dabkeviciene D; Life Sciences Center, Vilnius University, Sauletekio Ave., 7, Vilnius, LT 08412, Lithuania.
Kincius M; National Cancer Institute, Santariskiu Street 1, Vilnius, LT 08660, Lithuania.
Ulys A; National Cancer Institute, Santariskiu Street 1, Vilnius, LT 08660, Lithuania.
Suziedelis K; National Cancer Institute, Santariskiu Street 1, Vilnius, LT 08660, Lithuania.
Jarmalaite S; National Cancer Institute, Santariskiu Street 1, Vilnius, LT 08660, Lithuania.
Jankevicius F; Life Sciences Center, Vilnius University, Sauletekio Ave., 7, Vilnius, LT 08412, Lithuania.

J Oncol ; 2021: 8820366, 2021.

Article en En | MEDLINE | ID: mdl-33488712

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Oncol Año: 2021 Tipo del documento: Article País de afiliación: Lituania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google